Through the creation of a technology-based company, CONICET researcher Gabriel Rabinovich, along with colleagues from the organization and other specialists, seeks to transform three decades of scientific discoveries into new therapeutic strategies for the treatment of cancer, autoimmune diseases, and inflammatory conditions.
Full article: